drugset / Trial / NCT01667211
Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer
NaSingle-groupOpen-labelTreatment
Summary
Using albumin-bound paclitaxel and nedaplatin in the advanced or recurrent metastasis cervical cancer, to evaluate the efficacy and toxic reaction.
Timeline
- Start
- 2011-11
- Primary completion
- 2014-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nedaplatin | Small molecule | 80 mg/m2 | Intravenous |
| Subject | Nedaplatin | Small molecule | 100 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 200 mg/m2 | Intravenous |